Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACACB | O00763 | 13/20 | 0.52 |
| ▸ | ACACA | Q13085 | 13/20 | 0.52 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.33 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.33 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | WEE1 | P30291 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15894937 | 0.96 | ACACB (0.51) | ACACBACACATHRBCHRM2CHRM4 | |
| SCHEMBL18393305 | 0.96 | ACACB (0.51) | ACACBACACATHRBCHRM2CHRM4 | |
| Spirotetramat SCHEMBL27350845 | 0.94 | ACACB (0.49) | ACACBACACATHRBMEN1KMT2A | |
| Spirotetramat SCHEMBL337030 | 0.94 | ACACB (0.49) | ACACBACACATHRBMEN1KMT2A | |
| Spirotetramat SCHEMBL14855635 | 0.94 | ACACB (0.49) | ACACBACACATHRBMEN1KMT2A | |
| Spirotetramat SCHEMBL26389 | 0.94 | ACACB (0.49) | ACACBACACATHRBMEN1KMT2A | |
| Spirotetramat SCHEMBL12022413 | 0.94 | ACACB (0.49) | ACACBACACATHRBMEN1KMT2A | |
| Spirotetramat SCHEMBL2584908 | 0.93 | ACACB (0.49) | ACACBACACATHRBMEN1KMT2A | |
| SCHEMBL11932139 | 0.93 | ACACB (0.52) | ACACBACACATHRBCHRM2CHRM4 | |
| SCHEMBL2850600 | 0.93 | ACACB (0.54) | ACACBACACATHRBCHRM2CHRM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2114118-B1 | SAFEGUARDING SEED SAFETY OF TREATED SEEDS | BAYER CROPSCIENCE AG (DE) | 2012-09-12 | — | — | EP | claimed |
| US-20100130365-A1 | SAFEGUARDING SEED SAFETY OF TREATED SEEDS | BAYER CROPSCIENCE AG (DE) | 2010-05-27 | — | — | US | claimed |
| EP-2114118-B2 | SAFEGUARDING SEED SAFETY OF TREATED SEEDS | BAYER CROPSCIENCE AG (DE) | 2016-12-14 | — | — | EP | disclosed |
| US-9049813-B2 | Safeguarding seed safety of treated seeds | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2015-06-09 | — | — | US | disclosed |
| EP-2114118-B1 | SAFEGUARDING SEED SAFETY OF TREATED SEEDS | BAYER CROPSCIENCE AG (DE) | 2012-09-12 | — | — | EP | disclosed |
| US-20100130365-A1 | SAFEGUARDING SEED SAFETY OF TREATED SEEDS | BAYER CROPSCIENCE AG (DE) | 2010-05-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100130365-A1 | SAFEGUARDING SEED SAFETY OF TREATED SEEDS | TUBA3C, TUBB3, TUBA1C | ACACB 98/4885ACACA 145/4885THRB 4865/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.